4.6 Article

Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer

Sha-Sha Cheng et al.

Summary: CDK9 inhibition is a potential therapeutic strategy for TNBC, and compound 1 demonstrates promising anti-metastatic activity.

ACTA PHARMACEUTICA SINICA B (2022)

Article Biochemistry & Molecular Biology

Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked Benzenesulfonamide

Adel S. El-Azab et al.

Summary: New Schiff's bases based on quinazoline scaffold 4-27 were investigated for their inhibitory activity against human carbonic anhydrase isoforms I, II, IX, and XII. Some compounds showed potent inhibitory activity, comparable to the known inhibitor AZ, and demonstrated high selectivity towards different CA isoforms.

MOLECULES (2022)

Review Oncology

Targeting CDK9 for Anti-Cancer Therapeutics

Ranadip Mandal et al.

Summary: CDK9, in combination with Cyclin T1, plays a crucial role in RNA Polymerase II mediated transcription. Enhanced CDK9 activity in various cancers is associated with poor prognosis, leading to the development of small-molecule inhibitors targeting CDK9. Research is ongoing to develop more specific inhibitors and explore combination therapies with other regulators to enhance anti-cancer effects.

CANCERS (2021)

Review Oncology

Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches

Anna Richter et al.

Summary: Cyclin-dependent kinases are crucial in regulating cancer initiation processes in hematological neoplasms, with CDK inhibitors showing promising potential in treating these malignancies. However, selecting the right drug for different subgroups and patients remains challenging due to the complex molecular heterogeneity and clinical presentation. Biomarkers like chromosomal abnormalities and signaling molecule activities are being considered to aid in the identification of suitable CDK inhibitors for personalized treatment approaches.

CANCERS (2021)

Review Pharmacology & Pharmacy

Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2020)

Article Chemistry, Medicinal

CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?

Sarah Diab et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors

Ashraf N. Abdalla et al.

MOLECULES (2020)

Article Chemistry, Medicinal

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

Tizhi Wu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Chemistry, Medicinal

Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures

Weiyan Cheng et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors

Adel S. El-Azab et al.

BIOORGANIC CHEMISTRY (2019)

Review Chemistry, Medicinal

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)

Concepcion Sanchez-Martinez et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Review Chemistry, Medicinal

An overview of quinazolines: Pharmacological significance and recent developments

V. Alagarsamy et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016)

Abdul Hameed et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2018)

Review Chemistry, Multidisciplinary

Flavopiridol as cyclin dependent kinase (CDK) inhibitor: a review

Aakash Deep et al.

NEW JOURNAL OF CHEMISTRY (2018)

Review Chemistry, Medicinal

Recent advances on CDK inhibitors: An insight by means of in silico methods

Marco Tutone et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues

Adel S. El-Azab et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies

Amer M. Alanazi et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues

Ibrahim A. Al-Suwaidan et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists

Nam-Chul Cho et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

Concepcion Sanchez-Martinez et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Review Biotechnology & Applied Microbiology

The history and future of targeting cyclin-dependent kinases in cancer therapy

Uzma Asghar et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents

Amer M. Alanazi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Biotechnology & Applied Microbiology

The role of ligand efficiency metrics in drug discovery

Andrew L. Hopkins et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Biotechnology & Applied Microbiology

Cyclin-dependent kinases

Marcos Malumbres

GENOME BIOLOGY (2014)

Article Chemistry, Medicinal

Novel 4(3H)-quinazolinone analogs: synthesis and anticonvulsant activity

Adel S. El-Azab et al.

MEDICINAL CHEMISTRY RESEARCH (2013)

Article Chemistry, Medicinal

Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents

Hamad M. Alkahtani et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives

Adel S. El-Azab et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Design and synthesis of novel 7-aminoquinazoline derivatives: Antitumor and anticonvulsant activities

Adel S. El-Azab et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Review Pharmacology & Pharmacy

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

Vladimir Krystof et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Article Chemistry, Medicinal

Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents

Pawel M. Lukasik et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose) polymerase-1 inhibitors

Shridhar S. Kulkarni et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Chemistry, Multidisciplinary

Synthesis and anticonvulsant evaluation of some novel 4(3H)-quinazolinones

Adel S. El-Azab et al.

MONATSHEFTE FUR CHEMIE (2011)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study

Adel S. El-Azab et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Review Pharmacology & Pharmacy

Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology

Shudong Wang et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2008)

Article Chemistry, Inorganic & Nuclear

Synthesis of some new substituted 2-mercaptoquinazoline analogs as potential antimicrobial agents

Adel S. El-Azab

PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS (2007)